• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建并验证一个列线图模型,以预测接受对侧预防性乳房切除术的单侧乳腺癌患者的总体生存获益。

Construction and Validation of a Nomogram Predicting the Overall Survival Benefit of Unilateral Breast Cancer Patients Undergoing Contralateral Prophylactic Mastectomy.

机构信息

Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

School of Basic Medical Sciences, Xi'an Key Laboratory of Immune Related Diseases, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

出版信息

Clin Breast Cancer. 2024 Jun;24(4):351-362. doi: 10.1016/j.clbc.2024.02.001. Epub 2024 Feb 7.

DOI:10.1016/j.clbc.2024.02.001
PMID:38521702
Abstract

BACKGROUND

Currently, research on the prognostic factors of unilateral breast cancer (UBC) patients receiving contralateral prophylactic mastectomy (CPM) is limited. This study aimed to construct a new nomogram to predict these patients' overall survival (OS).

METHODS

In this retrospective study, 88,477 patients who underwent CPM or unilateral mastectomy (UM) were selected from the Surveillance, Epidemiology, and End Results database. Kaplan-Meier curves and Cox regression analyses were used to determine the difference in the impact of the 2 surgical methods on the prognosis. Multivariate Cox analysis was used to determine the best prognostic variable and construct a nomogram. The concordance index (C-index), receiver operating characteristic (ROC) curve, calibration curve, decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to evaluate the discrimination capability and clinical effectiveness of the nomogram.

RESULTS

The prognosis of patients receiving CPM and UM was significantly different. The DCA curves indicated that the nomogram could provide more excellent clinical net benefits for these patients. The NRI and IDI of the nomogram demonstrated that its performance was better than that of the classical tumor-node-metastasis (TNM) staging system.

CONCLUSION

This study developed and validated a practical nomogram to predict the OS of UBC patients undergoing CPM, which provided a beneficial tool for clinical decision-making management.

摘要

背景

目前,关于接受对侧预防性乳房切除术(CPM)的单侧乳腺癌(UBC)患者的预后因素的研究有限。本研究旨在构建一个新的列线图来预测这些患者的总生存(OS)。

方法

在这项回顾性研究中,从监测、流行病学和结果数据库中选择了 88477 名接受 CPM 或单侧乳房切除术(UM)的患者。Kaplan-Meier 曲线和 Cox 回归分析用于确定两种手术方法对预后的影响差异。多变量 Cox 分析用于确定最佳预后变量并构建列线图。一致性指数(C 指数)、接收者操作特征(ROC)曲线、校准曲线、决策曲线分析(DCA)、净重新分类改善(NRI)和综合判别改善(IDI)用于评估列线图的判别能力和临床效果。

结果

接受 CPM 和 UM 的患者的预后明显不同。DCA 曲线表明,该列线图可以为这些患者提供更优的临床净效益。列线图的 NRI 和 IDI 表明其性能优于经典的肿瘤-淋巴结-转移(TNM)分期系统。

结论

本研究开发并验证了一个实用的列线图,用于预测接受 CPM 的 UBC 患者的 OS,为临床决策管理提供了有益的工具。

相似文献

1
Construction and Validation of a Nomogram Predicting the Overall Survival Benefit of Unilateral Breast Cancer Patients Undergoing Contralateral Prophylactic Mastectomy.构建并验证一个列线图模型,以预测接受对侧预防性乳房切除术的单侧乳腺癌患者的总体生存获益。
Clin Breast Cancer. 2024 Jun;24(4):351-362. doi: 10.1016/j.clbc.2024.02.001. Epub 2024 Feb 7.
2
Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.基于 SEER 的回顾性研究:开发和验证用于预测原发性膀胱肉瘤患者总生存期的预后列线图。
BMC Urol. 2021 Nov 25;21(1):162. doi: 10.1186/s12894-021-00929-x.
3
Development and validation of a nomogram for predicting cancer-specific survival in small-bowel adenocarcinoma patients using the SEER database.基于 SEER 数据库的列线图模型构建与验证:用于预测小肠腺癌患者癌症特异性生存的研究。
World J Surg Oncol. 2024 Jun 7;22(1):151. doi: 10.1186/s12957-024-03438-x.
4
Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.构建和验证一种新型列线图预测小细胞肺癌合并患者总生存期的方法:一项监测、流行病学和最终结果的基于人群的研究。
Cancer Control. 2021 Jan-Dec;28:10732748211051228. doi: 10.1177/10732748211051228.
5
Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.对侧预防性乳房切除术的使用日益增加,尽管对浸润性乳腺癌的长期生存并无改善。
Ann Surg. 2017 Mar;265(3):581-589. doi: 10.1097/SLA.0000000000001698.
6
Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.基于人群的研究:开发和验证用于预测膀胱癌患者根治性膀胱切除术后癌症特异性生存的预后列线图。
Cancer Med. 2020 Dec;9(24):9303-9314. doi: 10.1002/cam4.3535. Epub 2020 Oct 16.
7
Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.美国 1998-2016 年 I-III 期单侧乳腺癌男性患者行对侧预防性乳房切除术的趋势和生存获益。
Breast Cancer Res Treat. 2021 Dec;190(3):503-515. doi: 10.1007/s10549-021-06397-z. Epub 2021 Sep 23.
8
Validating the 2023 FIGO staging system: A nomogram for endometrioid endometrial cancer and adenocarcinoma.验证 2023FIGO 分期系统:子宫内膜样子宫内膜癌和腺癌的列线图。
Cancer Med. 2024 May;13(10):e7216. doi: 10.1002/cam4.7216.
9
Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.开发并验证了一个列线图模型,用于预测接受新辅助放疗的可切除 N2 期非小细胞肺癌患者的总生存情况。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11779-11790. doi: 10.1007/s00432-023-05073-7. Epub 2023 Jul 5.
10
A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma.用于预测个体小肠腺癌患者癌症特异性生存的便捷临床列线图。
BMC Cancer. 2020 Jun 1;20(1):505. doi: 10.1186/s12885-020-06971-6.